Cited by 51Sexual function and dysfunction studiesPharmaceutical industry and healthcareGender and Feminist Studies

The 'pinking' of Viagra culture: drug industry efforts to create and repackage sex drugs for women.

Hartley, Heather·2006·Sexualities

Abstract

This essay will describe how the success of Viagra stimulated drug companies to create a women's sexual condition comparable to erectile problems in men for which they could market new sex drugs to women. The heart of the article focuses on two interrelated aspects of Viagra culture playing out in drug industry efforts to create and expand a market for sex drugs for women: (1) the industry's ‘Hunt for the Pink Viagra’ to treat the ‘disease’ of female sexual dysfunction (FSD), and (2) the prescription and promotion of off-label uses of men's sex drugs to women. In order to contextualize these two trends, the article outlines key activities and actions that have enabled the drug industry to consolidate power and build capacity in this area, including: mass dissemination of estimates of disease prevalence; the institutionalization of FSD in academic circles, which includes strategic revision of disease definitions as well as the creation of a legitimized infrastructure for dissemination of supporting research and education; and public-relations stimulated mainstream media coverage. The article concludes with a consideration of the ongoing challenges to the medicalization of women's sexuality as well as to harmful corporate practices more broadly.

Integrity signals

Registry

Crossref · 10.1177/1363460706065058

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hartley, H.
Affiliations
Portland State University (US)
Corresponding author
Hartley, Heather
Venue
Sexualities
Published
2006-07
Volume
9
Issue
3
Pages
363-378
ISSN
  • 1363-4607 (ISSN-L)
  • 1461-7382
OpenAlex
W1965223920
Cited by
51
References
34
Citations by year
2023: 1 · 2022: 2 · 2021: 4 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 5 · 2016: 1 · 2015: 4 · 2014: 3 · 2013: 4 · 2012: 4
FWCI
0.85
Type
journal article
Language
en
Open access
closed
Locations
Sexualities (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmaceutical industry and healthcare
  • Social Sciences › Gender Studies › Gender and Feminist Studies
Keywords
sildenafil, female sexual dysfunction, off-label drug use, organizational practices, pharmaceutical industry

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review